[Congressional Bills 115th Congress]
[From the U.S. Government Publishing Office]
[H.R. 5980 Introduced in House (IH)]

<DOC>






115th CONGRESS
  2d Session
                                H. R. 5980

 To authorize, develop, and implement a coordinated tracking system of 
  federally-funded initiatives and grant programs for substance abuse 
    treatment, prevention, and enforcement, and for other purposes.


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

                              May 25, 2018

 Mr. Rothfus introduced the following bill; which was referred to the 
              Committee on Oversight and Government Reform

_______________________________________________________________________

                                 A BILL


 
 To authorize, develop, and implement a coordinated tracking system of 
  federally-funded initiatives and grant programs for substance abuse 
    treatment, prevention, and enforcement, and for other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Coordinated Overdose and Drug 
Epidemic Response to the Emergency Declaration Act'' or the ``CODE RED 
Act''.

SEC. 2. AUTHORIZATION, DEVELOPMENT, AND IMPLEMENTATION OF A COORDINATED 
              TRACKING SYSTEM.

    (a) Establishment.--The Director, shall establish a coordinated 
tracking system of federally-funded initiatives and grant programs 
which shall--
            (1) be the central repository of all relevant grants;
            (2) identify duplication, overlap, or gaps in funding to 
        provide increased accountability of federally-funded grants for 
        substance abuse treatment, prevention, and enforcement;
            (3) identify impediments that applicants currently have in 
        the grant application process with applicable agencies; and
            (4) be developed and maintained by the Office with the 
        support of designated National Drug Control Program Agencies, 
        and any other agency determined by the Director.
    (b) Performance Metrics.--The Director shall identify metrics and 
achievable goals for grant recipients in furtherance of the Strategy. 
Such metrics should be used to measure how effective each federally-
funded initiative is in achieving the objectives of the Strategy and to 
enable comparisons of federally-funded initiatives to identify those 
that are the most cost effective.
    (c) Grant Application Standardization.--The Director, in 
consultation with the head of each National Drug Control Program 
Agency, shall develop a plan for coordinating and standardizing drug 
control grant application processes and develop a joint application to 
be used by all National Drug Control Program Agencies to reduce the 
administrative burden and improve oversight of Federal funds.
    (d) Central Portal.--The Director shall maintain on the public, 
electronic portal of the Office a list all drug control grant award 
opportunities available in a central location. The head of each 
National Drug Control Program Agency shall provide a complete list of 
all drug control program grant award opportunities to the Director and 
annually update such list.
    (e) Report to Congress.--Not later than 180 days after the date of 
the enactment of this Act, the Director shall submit to Congress a 
report on progress under this section and the feasibility of block 
grants of Federal funding to States.
    (f) Definitions.--In this section:
            (1) Agency.--The term ``agency'' has the meaning given the 
        term ``executive agency'' in section 102 of title 31, United 
        States Code.
            (2) Demand reduction.--The term ``demand reduction'' means 
        any activity conducted by a National Drug Control Program 
        Agency, other than an enforcement activity, that is intended to 
        reduce or prevent the use of drugs or support or provide 
        treatment and recovery efforts, including--
                    (A) education about the dangers of illicit drug 
                use;
                    (B) services, programs, or strategies to prevent 
                substance use disorder, including evidence-based 
                education campaigns, community-based prevention 
                programs, opioid diversion, collection and disposal of 
                unused prescription drugs, and services to at-risk 
                populations to prevent or delay initial use of an 
                illicit substance;
                    (C) substance use disorder treatment;
                    (D) illicit drug use research;
                    (E) drug-free workplace programs;
                    (F) drug testing, including the testing of 
                employees;
                    (G) interventions for illicit drug use and 
                dependence;
                    (H) expanding availability of access to health care 
                services for the treatment of substance use disorders;
                    (I) international drug control coordination and 
                cooperation with respect to activities described in 
                this paragraph;
                    (J) pre- and post-arrest criminal justice 
                interventions such as diversion programs, drug courts, 
                and the provision of evidence-based treatment to 
                individuals with substance use disorders who are 
                arrested or under some form of criminal justice 
                supervision, including medication assisted treatment;
                    (K) other coordinated and joint initiatives among 
                Federal, State, local, and Tribal agencies to promote 
                comprehensive drug control strategies designed to 
                reduce the demand for, and the availability of, illegal 
                drugs;
                    (L) international illicit drug use education, 
                prevention, treatment, recovery, research, 
                rehabilitation activities, and interventions for 
                illicit drug use and dependence; and
                    (M) research related to any of the activities 
                described in this paragraph.
            (3) Director.--The term ``Director'' means the Director of 
        the Office of National Drug Control Policy.
            (4) Drug control.--The term ``drug control'' means any 
        activity conducted by a National Drug Control Program Agency 
        involving supply reduction or demand reduction.
            (5) Illicit drug use; illicit drugs; illegal drugs.--The 
        terms ``illicit drug use'', ``illicit drugs'', and ``illegal 
        drugs'' include the illegal or illicit use of prescription 
        drugs.
            (6) National drug control program agency.--The term 
        ``National Drug Control Program Agency'' means any agency (or 
        bureau, office, independent agency, board, division, 
        commission, subdivision, unit, or other component thereof) that 
        is responsible for implementing any aspect of the National Drug 
        Control Strategy, including any agency that receives Federal 
        funds to implement any aspect of the National Drug Control 
        Strategy, but does not include any agency that receives funds 
        for drug control activity solely under the National 
        Intelligence Program or the Military Intelligence Program.
            (7) Office.--The term ``Office'' means the Office of 
        National Drug Control Policy.
            (8) Strategy.--The term ``Strategy'' means the National 
        Drug Control Program Strategy.
            (9) Supply reduction.--The term ``supply reduction'' means 
        any activity or program conducted by a National Drug Control 
        Program Agency that is intended to reduce the availability or 
        use of illegal drugs in the United States or abroad, 
        including--
                    (A) law enforcement outside the United States;
                    (B) domestic law enforcement;
                    (C) source country programs, including economic 
                development programs primarily intended to reduce the 
                production or trafficking of illicit drugs;
                    (D) activities to control international trafficking 
                in, and availability of, illegal drugs, including--
                            (i) accurate assessment and monitoring of 
                        international drug production and interdiction 
                        programs and policies; and
                            (ii) coordination and promotion of 
                        compliance with international treaties relating 
                        to the production, transportation, or 
                        interdiction of illegal drugs;
                    (E) activities to conduct and promote international 
                law enforcement programs and policies to reduce the 
                supply of drugs;
                    (F) activities to facilitate and enhance the 
                sharing of domestic and foreign intelligence 
                information among National Drug Control Program 
                Agencies, relating to the production and trafficking of 
                drugs in the United States and in foreign countries;
                    (G) activities to prevent the diversion of drugs 
                for their illicit use; and
                    (H) research related to any of the activities 
                described in this paragraph.
                                 <all>